Abstract: A triangle ruler includes a triangle ruler body defining three corners, three sides, opposing first surface and second surface surrounded by the three sides and three corners and a recessed annular scale located at the center thereof, and a direction indicator including a pendulum and a pointer and pivoting about the center of the recessed annular scale in such a manner that the pivot axis of the direction indicator extends perpendicular to the first and second surfaces of the triangle ruler body, and the effects of the weight of the direction indicator keeps one end of the pointer to constantly indicate a predetermined direction. Thus, the invention combines the functions of a conventional protractor and a conventional triangle ruler to facilitate drawing a variety of different angles of lines.

Abstract: A vehicle unlocking device includes a first rod, a second rod, a first connecting member, a second connecting member, and a lock device. Therein, the first rod has one end as a handle and the other end as a first fixing part. The second rod has one end as a bended hook part and the other end as a second fixing part. The first connecting member is fixed to the first fixing part. The second connecting member is fixed to the second fixing part and sleeves the first connecting member, while the first and second connecting members are kept from rotating against each other. The lock device is in between the first and second connecting members for manipulating the axial detachment of the second connecting member from the first, connecting member.

Abstract: The present invention provides a kind of benzopyrone compounds having a structure of formula (I) and the pharmaceutically acceptable salts or prodrugs thereof, and the pharmaceutical compositions containing such compounds, which can be used to regulate the novel estrogen receptor ER-a36, and prevent and/or treat the related diseases mediated by the ER-a36 receptor, such as cancers, etc.

Abstract: A triangle ruler includes a triangle ruler body defining three corners, three sides, opposing first surface and second surface surrounded by the three sides and three corners and a recessed annular scale located at the center thereof, and a direction indicator including a pendulum and a pointer and being pivotally connected to the center of the recessed annular scale in such a manner that the axial direction of the direction indicator passes through the first and second surfaces of the triangle ruler body, and the effects of the weight of the direction indicator keeps one end of the pointer to constantly indicate a predetermined direction. Thus, the invention combines the functions of a conventional protractor and a conventional triangle ruler to facilitate drawing a variety of different angles of lines.

Abstract: The present invention is directed to chromenone compounds of formula (I), pharmaceutically acceptable salts, prodrugs thereof, and the composition comprising the compounds or the like. They can be used to modulating the function of estrogen receptor ER-?36 preventing and/or treating the estrogen related diseases, such as breast cancer, leukemia, liver cancer and etc.

Abstract: The present invention provides the use of Icaritin for the preparation of a composition for treating cancer, wherein the composition is orally administered to a patient at least one cycle, each cycle comprising a continuous 28-day dosing schedule, in which Icaritin is administered at least once daily, at a dosage of 400-1800 mg daily. The patients treated with Icaritin according to the present method receive better treatment, with reduced adverse effects.

Abstract: The present invention provides a kind of benzopyrone compounds having a structure of formula (I) and the pharmaceutically acceptable salts or prodrugs thereof, and the pharmaceutical compositions containing such compounds, which can be used to regulate the novel estrogen receptor ER-a36, and prevent and/or treat the related diseases mediated by the ER-a36 receptor, such as cancers, etc.

Abstract: The present invention relates to a novel phytase enzyme, a novel isolated nucleic acid molecule coding the enzyme, and a novel Yersinia intermedia having phytase activity. Particularly, the present invention relates to the phytase having (a) Theoretical molecular weight 45.5 kDa, (b) high specific activity 3960±248 U/mg, (c) high stability at high temperature and wide pH, (d) optimal pH of 4.0-5.0, (e) optimal temperature of 50-60° C., (f) high resistance to pepsin and trypsin. The phytase is very suitable to be used in feed of monogastrics as feed additive. The present invention also relates to a recombinant vector comprising said nucleic acid molecule, a recombinant host cell (e.g., Pichia pastoris) harboring said recombinant vector, and a method for producing phytase using the recombinant host cell. The present invention further provides a feed additive comprising said phytase and/or host cells expressing a phytase as effective ingredient.

Abstract: A cutting tool with an adjustable cutting angle includes a first shank ended by a cutting blade, a second shank pivotally connected to the first shank so that the first and second shanks can be drawn toward or away mutually, an anvil provided on the second shank in positional correspondence to the cutting blade so as to work with the cutting blade and cut, wherein the anvil having a board-like body extending along the second shank is formed with an axial hole and edged with a curved sliding rim, and a pivotable retaining plate having its one end mounted around a shaft in the axial hole and its opposite end formed with a notch for engaging with the sliding rim, so that the pivotable retaining plate can pivot against the anvil, thereby making an angle between the retaining plate and the cutting blade, namely the cutting angle vary.

Abstract: Provided herein in certain embodiments are compounds, pharmaceutical compositions and methods for modulating the functions of estrogen receptor alpha 36, for preventing and/or treating diseases related to estrogen receptor alpha 36, for preventing and/or treating respiratory diseases such as asthma, for inducing cell death and/or inhibiting cell proliferation and for preventing and/or treating diseases involving abnormal cell proliferation such as cancers.

Abstract: A beveled-edge maker (1) for chamfering a workpiece (2), the tool comprising a knife assembly (4) adapted for attaching to a drive (5), and at least one guider (8) adapted such that the beveled-edge maker can be mounted to the edge of the workpiece and moved there along.

Abstract: Provided herein in certain embodiments are antibodies, antibody fragments, pharmaceutical compositions, methods for modulating the functions of estrogen receptor alpha 36, and methods for preventing and/or treating diseases mediated by estrogen receptor alpha 36.

Abstract: The present invention relates to a novel phytase enzyme, a novel isolated nucleic acid molecule coding the enzyme, and a novel Yersinia intermedia having phytase activity. Particularly, the present invention relates to the phytase having (a) Theoretical molecular weight 45.5 kDa, (b) high specific activity 3960±248 U/mg, (c) high stability at high temperature and wide pH, (d) optimal pH of 4.0-5.0, (e) optimal temperature of 50-60° C., (f) high resistance to pepsin and trypsin. The phytase is very suitable to be used in feed of monogastrics as feed additive. The present invention also relates to a recombinant vector comprising said nucleic acid molecule, a recombinant host cell (e.g., Pichia pastoris) harboring said recombinant vector, and a method for producing phytase using the recombinant host cell. The present invention further provides a feed additive comprising said phytase and/or host cells expressing a phytase as effective ingredient.

Abstract: Provided herein in certain embodiments are compounds, pharmaceutical compositions and methods for modulating the functions of estrogen receptor alpha 36, for preventing and/or treating diseases mediated by estrogen receptor alpha 36, for preventing and/or treating osteoporosis, for inducing cell death and/or inhibiting cell proliferation and for preventing and/or treating diseases involving abnormal cell proliferation such as cancers.

Abstract: A ribbon gun includes a body having a trigger mechanism received therein and a magazine is received in the body portion. The magazine includes multiple cartridges and ribbons in the cartridges can be ejected by pulling the trigger mechanism. A cover has an outlet and is pivotably connected to the front end of the body. A locking member and a pivot are connected to the cover. The locking member secures the cover to the body, and the pivot is pivotably connected to the body. A pressing portion extends from a rear side thereof which faces interior of the body and a centering piece is located at a center of the pressing portion. The pressing portion presses the board of the magazine to push the cartridges toward the impact rod of the trigger mechanism. The centering piece is engaged with a recess in the board.